<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">30490</article-id><article-id pub-id-type="doi">10.7554/eLife.30490</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>A homozygous <italic>FANCM</italic> mutation underlies a familial case of non-syndromic primary ovarian insufficiency</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-94709"><name><surname>Fouquet</surname><given-names>Baptiste</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94710"><name><surname>Pawlikowska</surname><given-names>Patrycja</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94711"><name><surname>Caburet</surname><given-names>Sandrine</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7404-8213</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94712"><name><surname>Guigon</surname><given-names>Celine</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94713"><name><surname>Mäkinen</surname><given-names>Marika</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94714"><name><surname>Tanner</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94715"><name><surname>Hietala</surname><given-names>Marja</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101366"><name><surname>Urbanska</surname><given-names>Kaja</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101367"><name><surname>Bellutti</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101368"><name><surname>Legois</surname><given-names>Bérangère</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94717"><name><surname>Bessieres</surname><given-names>Bettina</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94718"><name><surname>Gougeon</surname><given-names>Alain</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94719"><name><surname>Benachi</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94720"><name><surname>Livera</surname><given-names>Gabriel</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94721"><name><surname>Rosselli</surname><given-names>Filippo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17061"><name><surname>Veitia</surname><given-names>Reiner A</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-93028"><name><surname>Misrahi</surname><given-names>Micheline</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5379-8859</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Hopital Bicetre</institution>, <institution>Faculté de médecine Paris Sud</institution>, <addr-line><named-content content-type="city">Le Kremlin Bicetre</named-content></addr-line>, <country>France</country></aff><aff id="aff2"><institution content-type="dept">CNRS UMR8200</institution>, <institution>Université Paris Sud</institution>, <addr-line><named-content content-type="city">Villejuif</named-content></addr-line>, <country>France</country></aff><aff id="aff3"><institution content-type="dept">Molecular Oncology and Ovarian Pathologies, Institut Jacques Monod</institution>, <institution>Université Paris Diderot</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff4"><institution content-type="dept">CNRS, UMR 8251, INSERM, U1133</institution>, <institution>Université Paris Diderot</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff5"><institution content-type="dept">Department of Clinical Genetics</institution>, <institution>Turku University Hospital</institution>, <addr-line><named-content content-type="city">Turku</named-content></addr-line>, <country>Finland</country></aff><aff id="aff6"><institution content-type="dept">UMR967 INSERM, CEA/DRF/iRCM/SCSR/LDG</institution>, <institution>Université Paris Diderot</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff7"><institution content-type="dept">Institut Jacques Monod</institution>, <institution>Université Paris Diderot</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff8"><institution content-type="dept">Department of Histology, Embryology and Cytogenetics</institution>, <institution>Hôpital Necker-enfants malades, APHP</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff9"><institution content-type="dept">UMR Inserm 1052, CNRS 5286</institution>, <institution>Faculté de Médecine Laennec</institution>, <addr-line><named-content content-type="city">Lyon</named-content></addr-line>, <country>France</country></aff><aff id="aff10"><institution content-type="dept">Department of Obstetrics and Gynaecology</institution>, <institution>Université Paris Sud</institution>, <addr-line><named-content content-type="city">Clamart</named-content></addr-line>, <country>France</country></aff><aff id="aff11"><institution content-type="dept">UMR967 INSERM, CEA/DRF/iRCM/SCSR/LDG</institution>, <institution>Université Paris Diderot</institution>, <addr-line><named-content content-type="city">Fontenay aux Roses</named-content></addr-line>, <country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-94662"><name><surname>Deans</surname><given-names>Andrew</given-names></name><role>Reviewing editor</role><aff><institution>St Vincent's Institute of Medical Research</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Micheline.misrahi@aphp.fr</email> (MM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>12</day><month>12</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e30490</elocation-id><history><date date-type="received"><day>18</day><month>07</month><year>2017</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Fouquet et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Fouquet et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-30490-v1.pdf"/><abstract><p>Primary Ovarian Insufficiency (POI) affects ~1% of women under forty. Exome sequencing of two Finnish sisters with non-syndromic POI revealed a homozygous mutation in <italic>FANCM,</italic> leading to a truncated protein (p.Gln1701*). <italic>FANCM</italic> is a DNA-damage response gene whose heterozygous mutations predispose to breast cancer. Compared to the mother's cells, the patients' lymphocytes displayed higher levels of basal and mitomycin C (MMC)-induced chromosomal abnormalities. Their lymphoblasts were hypersensitive to MMC and MMC-induced monoubiquitination of FANCD2 was impaired. Genetic complementation of patient's cells with wild-type FANCM improved their resistance to MMC re-establishing FANCD2 monoubiquitination<italic>FANCM</italic> was more strongly expressed in human fetal germ cells than in somatic cells. FANCM protein was preferentially expressed along the chromosomes in pachytene cells, which undergo meiotic recombination. This mutation may provoke meiotic defects leading to a depleted follicular stock, as in <italic>Fancm<sup>-/-</sup></italic> mice. Our findings document the first Mendelian phenotype due to a biallelic <italic>FANCM</italic> mutation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002915</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>DEQ20150331757</award-id><principal-award-recipient><name><surname>Fouquet</surname><given-names>Baptiste</given-names></name><name><surname>Caburet</surname><given-names>Sandrine</given-names></name><name><surname>Veitia</surname><given-names>Reiner A</given-names></name><name><surname>Misrahi</surname><given-names>Micheline</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004099</institution-id><institution>Ligue Contre le Cancer</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Pawlikowska</surname><given-names>Patrycja</given-names></name><name><surname>Rosselli</surname><given-names>Filippo</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study was approved by all the institutions involved. All participants gave informed consent for the study and the study was approved by the agence de Biomedecine (reference number PFS12-002).</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-30490-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>